Development of quality indicators for hypertension management at the primary health care level in South Africa.


Journal

Journal of human hypertension
ISSN: 1476-5527
Titre abrégé: J Hum Hypertens
Pays: England
ID NLM: 8811625

Informations de publication

Date de publication:
14 Oct 2024
Historique:
received: 07 04 2024
accepted: 02 10 2024
revised: 16 09 2024
medline: 15 10 2024
pubmed: 15 10 2024
entrez: 14 10 2024
Statut: aheadofprint

Résumé

Despite many quality initiatives at the primary health care (PHC) level, little is known about the actual quality of care of patients diagnosed with hypertension in South Africa. This study aimed to develop quality indicators for hypertension management at the PHC level to improve the quality of care and patient outcomes. The RAND/UCLA Appropriateness Method, comprising two rounds, was used to develop clear, appropriate, and feasible evidence-based quality indicators for hypertension. In Round 1, a 9-point scale was used by a panel of 11 members to rate clarity and appropriateness of 102 hypertension quality indicator statements, grouped under 9 dimensions of quality hypertension management, using an online MS Excel® spreadsheet. In Round 2, 9 of the same panellists discussed all indicators and rated their appropriateness and feasibility during a remote online, interactive face-to-face MS Teams® meeting. Statements rated ≥7-9 with agreement were defined as either appropriate or feasible. The panel rated 46 hypertension quality indicator statements ≥7-9 with agreement for the appropriate and feasible measurement of the management of hypertension: monitoring (n = 16), review (n = 5), lifestyle advice (n = 9), tests (n = 7), intermediate outcomes (n = 6), referrals (n = 2) and practice/facility structures (n = 1). No indicator statements were rated both appropriate and feasible for measuring blood pressure levels and treatment. If applied, these indicators would improve monitoring and management of patients with hypertension, patient outcomes, and data quality in South Africa and result in more efficient use of scarce resources. This study can be replicable for improving care of other non-communicable diseases across Africa.

Identifiants

pubmed: 39402282
doi: 10.1038/s41371-024-00966-7
pii: 10.1038/s41371-024-00966-7
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : National Research Foundation (NRF)
ID : UID No. 129079
Organisme : NRF | South African Agency for Science and Technology Advancement (SAASTA)
ID : UID No. 129079
Organisme : NRF | South African Agency for Science and Technology Advancement (SAASTA)
ID : UID No. 129079
Organisme : NRF | South African Agency for Science and Technology Advancement (SAASTA)
ID : UID No. 129079
Organisme : NRF | South African Agency for Science and Technology Advancement (SAASTA)
ID : UID No. 129079

Informations de copyright

© 2024. The Author(s).

Références

National Department of Health. National Strategic Plan for the Prevention and Control of Non-Communicable Diseases, 2022-7. Republic of South Africa. 2022. https://www.sancda.org.za/wp-content/uploads/2022/05/NCD-NSP-draft-layout-28-04-22.pdf .
Republic of South Africa. 1996, Constitution of the Republic of South Africa. Government Gazette. 2014. https://www.gov.za/documents/constitution/constitution-republic-southafrica-1996-1 . Accessed 16 Mar 2024.
World Health Organisation. South Africa. Country health topics, Universal Health Coverage. 2023 (a). https://www.afro.who.int/countries/south-africa .
National Department of Health (NDoH). Adherence guidelines for HIV, TB and NCDs. Republic of South Africa. 2016. Policy and service delivery guidelines for linkage to care, adherence to treatment and retention in care. 2016. https://www.knowledgehub.org.za/system/files/elibdownloads/2020-08/15%202%2016%20AGL%20policy%20and%20service%20delivery%20guidelines_0.pdf .
National Department of Health. National user guide on the prevention and treatment of hypertension in adults at the PHC level 2021. Republic of South Africa. 2021. https://www.knowledgehub.org.za/system/files/elibdownloads/2021-11/HYPERTENSION%20USER%20GUIDE%20FINAL%20COPY.pdf . Accessed 16 March 2024.
Price G National Health Insurance. South African Government. 2024. https://www.gov.za/blog/national-health-insurance . Accessed on 28 Feb 2024.
Makoni M. South Africa passes National Health Insurance Bill. Lancet. 2023;401:2101 https://doi.org/10.1016/S0140-6736(23)01294-1 .
doi: 10.1016/S0140-6736(23)01294-1 pubmed: 37356437
Magodoro IM, Olivier S, Gareta D, Koole O, Modise TH, Gunda R, et al. Linkage to HIV care and hypertension and diabetes control in rural South Africa: Results from the population-based Vukuzazi Study. PLOS Glob Public Health. 2022;2:e0001221. https://doi.org/10.1371/journal.pgph.0001221 .
World Health Organisation. Noncommunicable Diseases Progress Monitor 2022. World Health Organization. 2022. https://iris.who.int/bitstream/handle/10665/353048/9789240047761-eng.pdf?sequence=1 . Accessed 21 Mar 2024.
Mokwena K, Modutoane M. Poorly controlled hypertension among adults treated for hypertension in Tshwane District, South Africa. J Family Med Prim Care. 2022;11:7048–54. https://doi.org/10.4103/jfmpc.jfmpc_740_22 .
doi: 10.4103/jfmpc.jfmpc_740_22 pubmed: 36993082 pmcid: 10041214
Campbell SM, Godman B, Diogene E, Fürst J, Gustafsson LL, MacBride-Stewart S, et al. Quality indicators as a tool in improving the introduction of new medicines. Basic Clin Pharmacol Toxicol. 2015;116:146–57. https://doi.org/10.1111/bcpt.12295 .
doi: 10.1111/bcpt.12295 pubmed: 25052464
Rampamba EM, Meyer JC, Helberg E, Godman B. Medicines Availability among Hypertensive Patients in Primary Health Care Facilities in a Rural Province in South Africa: Findings and Implications. J Res Pharm Pract. 2021;11:181–5. https://doi.org/10.4103/jrpp.JRPP_20_49 .
Kohli-Lynch CN, Erzse A, Rayner BL, Hofman KJ. Hypertension in the South African public healthcare system: a cost-of-illness and burden of disease study. BMJ Open. 2022;12:e055621 https://doi.org/10.1136/bmjopen-2021-055621 .
doi: 10.1136/bmjopen-2021-055621 pubmed: 35193918 pmcid: 8867372
Brettler JW, Arcila GPG, Aumala T, Best A, Campbell NR, Cyr S et al. Drivers and scorecards to improve hypertension control in primary care practice: Recommendations from the HEARTS in the Americas Innovation Group. Lancet Reg Health Am. 2022;9. https://doi.org/10.1016/j.lana.2022.100223 .
World Health Organization, Organisation for Economic Co-operation and Development, The World Bank. Delivering quality health services: a global imperative for universal health coverage. Geneva. 2018. https://rhap.org.za/wp-ontent/uploads/2022/12/Full-RHAP-COVID-HSSdigi.pdf . Accessed 08 Dec 2023.
World Health Organisation. Monitoring the building blocks of health systems: a handbook of indicators and their measurement strategies. WHO. 2010. https://iris.who.int/bitstream/handle/10665/258734/9789241564052-eng.pdf . Accessed on 10 Dec 2023.
Manne-Goehler J, Geldsetzer P, Agoudavi K, Andall-Brereton G, Aryal KK, Bicaba BW, et al. Health system performance for people with diabetes in 28 low- and middle-income countries: A cross-sectional study of nationally representative surveys. PLoS Med. 2019;16:e1002751. https://doi.org/10.1371/journal.pmed.1002751 .
World Health Organisation. Global strategy on human resources for health: Workforce 2030. 2016. https://apps.who.int/iris/bitstream/handle/10665/250368/9789241511131-eng.pdf;jsessionid=124BC8A53893812B0683807B9E04F50D?sequence . Accessed 16 Mar 2024.
Leporowski A, Godman B, Kurdi A, MacBride-Stewart S, Ryan M, Hurding S, et al. Ongoing activities to optimize the quality and efficiency of lipid-lowering agents in the Scottish national health service: influence and implications. Expert Rev Pharmacoecon Outcomes Res. 2018;18:655–66. https://doi.org/10.1080/14737167.2018.1501558 .
doi: 10.1080/14737167.2018.1501558 pubmed: 30014725
Hinneh T, Akyirem S, Bossman IF, Lambongang V, Ofori-Aning P, Ogungbe O, et al. Regional prevalence of hypertension among people diagnosed with diabetes in Africa, a systematic review and meta-analysis. PLOS Glob Public Health. 2023;3:e0001931 https://doi.org/10.1371/journal.pgph.0001931 .
doi: 10.1371/journal.pgph.0001931 pubmed: 38051707 pmcid: 10697518
Fitch K, Bernstein SJ, Aguilar MD, Burnand B, LaCalle JR, Lázaro P et al. The RAND/UCLA Appropriateness Method User’s Manual. 2001. https://www.rand.org/pubs/monograph_reports/MR1269.html . Accessed 16 Mar 2024.
Campbell SM, Bell BG, Marsden K, Spencer R, Kadam U, Perryman K, et al. A Patient Safety Toolkit for Family Practices. J Patient Saf. 2020;16:e182–e186. https://doi.org/10.1097/PTS.0000000000000471 .
doi: 10.1097/PTS.0000000000000471 pubmed: 29461334
National Department of Health. Standard Treatment Guidelines and Essential Medicines List for South Africa. Primary Healthcare Level 2020 Edition., Online, https://www.knowledgehub.org.za/system/files/elibdownloads/2021-02/Primary%20Healthcare%20STGs%20and%20EML%207th%20edition%20-%202020-v2.0.pdf (2020).
National Institute for Health and Care Excellence (NICE). NICE quality and outcomes framework indicators. 2020. https://www.nice.org.uk/standards-and-indicators/index/All/hypertension .
Pan American Health Organisation (PAHO). Monitoring and evaluation framework for hypertension control programs. Washington, DC. 2018. https://iris.paho.org/bitstream/handle/10665.2/34877/PAHONMH18001_eng.pdf?sequence=6&isAllowed=y . Accessed 16 Mar 2024.
Campbell SM, Kontopantelis E, Hannon K, Burke M, Barber A, Lester HE. Framework and indicator testing protocol for developing and piloting quality indicators for the UK quality and outcomes framework. BMC Fam Pract. 2011;12:85 https://doi.org/10.1186/1471-2296-12-85 .
doi: 10.1186/1471-2296-12-85 pubmed: 21831317 pmcid: 3176158
Jünger S, Payne SA, Brine J, Radbruch L, Brearley SG. Guidance on Conducting and REporting DElphi Studies (CREDES) in palliative care: Recommendations based on a methodological systematic review. Palliat Med. 2017;31:684–706. https://doi.org/10.1177/0269216317690685 .
doi: 10.1177/0269216317690685 pubmed: 28190381
Broder MS, Gibbs SN, Yermilov I. An Adaptation of the RAND/UCLA Modified Delphi Panel Method in the Time of COVID-19. J Healthc Leadersh. 2022;14:63–70. https://doi.org/10.2147/JHL.S352500 .
doi: 10.2147/JHL.S352500 pubmed: 35634010 pmcid: 9130741
Tsang JY, Murray J, Kingdon E, Tomson C, Hallas K, Campbell S, et al. Guidance for post-discharge care following acute kidney injury: an appropriateness ratings evaluation. BJGP Open. 2020;4:bjgpopen20X101054 https://doi.org/10.3399/bjgpopen20X101054 .
doi: 10.3399/bjgpopen20X101054 pubmed: 32546580 pmcid: 7465579
Gassner L, Zechmeister-Koss I, Reinsperger I. National Strategies for Preventing and Managing Non-communicable Diseases in Selected Countries. Front Public Health. 2022;10:838051. https://doi.org/10.3389/fpubh.2022.838051 .
Shin J, Konlan KD. Prevalence and determinants of medication adherence among patients taking antihypertensive medications in Africa: A systematic review and meta-analysis 2010-2021. Nurs Open. 2023;10:3506–18. https://doi.org/10.1002/nop2.1613 .
doi: 10.1002/nop2.1613 pubmed: 36693022 pmcid: 10170912
Verdecchia P, Reboldi G, Angeli F. The 2020 International Society of Hypertension global hypertension practice guidelines - key messages and clinical considerations. Eur J Internal Med. 2020;82:1–6.
doi: 10.1016/j.ejim.2020.09.001
World Health Organization. Access to NCD medicines: emergent issues during the COVID-19 pandemic and key structural factors. Geneva. 2023 (b). Licence: CC BY-NC-SA 3.0 IGO. Available from: https://iris.who.int/bitstream/handle/10665/366528/9789240069442-eng.pdf?isAllowed=y&sequence=1 . Accessed on 09 Dec 2023.
Donabedian A. Evaluating the quality of medical care. 1966. Milbank Q. 2005;83:691–729. https://doi.org/10.1111/j.1468-0009.2005.00397.x .
doi: 10.1111/j.1468-0009.2005.00397.x pubmed: 16279964 pmcid: 2690293
Thilly N, Pereira O, Schouten J, Hulscher ME, Pulcini C. Proxy indicators to estimate appropriateness of antibiotic prescriptions by general practitioners: a proof-of-concept cross-sectional study based on reimbursement data, north-eastern France 2017. Euro Surveill. 2020;25:1900468 https://doi.org/10.2807/1560-7917 .
doi: 10.2807/1560-7917 pubmed: 32672150 pmcid: 7364760

Auteurs

Enos Muisaphanda Rampamba (EM)

Department of Public Health Pharmacy and Management, School of Pharmacy, Sefako Makgatho Health Sciences University, Pretoria, South Africa. mrampamba@gmail.com.
Division of Pharmacy Education, Professional Affairs, South African Pharmacy Council, Pretoria, 0001, South Africa. mrampamba@gmail.com.

Johanna Catharina Meyer (JC)

Department of Public Health Pharmacy and Management, School of Pharmacy, Sefako Makgatho Health Sciences University, Pretoria, South Africa.

Brian Godman (B)

Department of Public Health Pharmacy and Management, School of Pharmacy, Sefako Makgatho Health Sciences University, Pretoria, South Africa.
Department of Pharmacoepidemiology, Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow, United Kingdom.

Ntodeni Norah Ndwamato (NN)

Department of Family Medicines, School of Medicine, University of Limpopo, Polokwane, South Africa.
Limpopo Department of Health, Limpopo, Polokwane, South Africa.

Stephen Mark Campbell (SM)

Department of Public Health Pharmacy and Management, School of Pharmacy, Sefako Makgatho Health Sciences University, Pretoria, South Africa.
Centre for Epidemiology and Public Health, School of Health Sciences, University of Manchester, Manchester, United Kingdom.

Classifications MeSH